LOLA treatment (RRS HA Long Lasting): everything you need to know about skin hydration and rejuvenation

KEIT Day Hospital has clinical facilities dedicated to aesthetic medicine treatments, organised to ensure appropriate standards of hygiene, procedural precision and patient comfort.
For LOLA treatment, the doctor assesses skin condition and identifies areas requiring greater hydration and improvement in skin texture. RRS HA Long Lasting is administered through microinjections, using fine, sterile, single-use needles and techniques selected according to the anatomical characteristics of the area.
The organisation of the clinical facilities and the availability of medical resources allow the different stages of the procedure to be managed, from skin preparation to observation immediately after treatment.

KEIT Day Hospital works with medical professionals experienced in aesthetic medicine, skin biorevitalisation treatments and hyaluronic acid injection techniques. For LOLA treatment, knowledge of skin anatomy is essential for identifying injection areas, selecting the appropriate technique and distributing the product in a controlled manner.
Treatment is personalised according to the degree of dehydration, loss of elasticity and skin characteristics, prioritising a gradual and natural improvement in skin quality.
An additional advantage is the presence of a multidisciplinary medical team within KEIT Day Hospital, allowing specialists in anaesthesia and intensive care or other medical disciplines to be involved when additional assessments or specific medical assistance are required.

Before LOLA treatment, the doctor carries out an individual assessment of skin hydration, elasticity, texture and the presence of fine lines. The consultation includes taking a medical history, with particular attention to allergies, medications being taken, previous aesthetic treatments, skin infections and possible contraindications.
The assessment makes it possible to identify areas that may benefit from treatment and establish a personalised treatment plan. The number of sessions, intervals between applications and quantity of product are determined according to the initial skin condition, the product's indications and the patient's aesthetic goals. When LOLA is not the most appropriate solution, the doctor assesses possible alternative treatments and discusses their benefits and limitations.

KEIT Day Hospital follows hygiene and infection prevention protocols that include disinfecting clinical areas, skin antisepsis and the use of sterile, single-use devices during injectable treatments. For LOLA treatment, particular attention is paid to skin preparation, needle handling and checking the product packaging.
RRS HA Long Lasting is a stabilised hyaluronic acid formulation used to improve hydration and the superficial characteristics of the skin. Administration is planned according to the product's instructions for use and individual needs. The brand name, batch number, quantity administered and treated areas are recorded in the clinical documentation, ensuring traceability of the procedure.

LOLA treatment is a minimally invasive procedure, generally performed without general anaesthesia. When necessary, a topical anaesthetic may be applied to improve patient comfort. Hyaluronic acid microinjections also require medical expertise and adequate preparation for managing complications.
In addition to temporary effects such as redness, swelling and minor bruising, allergic reactions, infections, nodules or other injection-related complications may occur. Although rare, vascular complications require particular attention, especially in facial treatments. Prompt recognition of symptoms and activation of specific protocols are essential.
One of KEIT Day Hospital's distinguishing features is the availability of hospital infrastructure and a multidisciplinary medical team. The facility has three equipped operating theatres, specialists in anaesthesia and intensive care, equipment for monitoring vital signs, emergency management devices and a postoperative recovery room. These resources provide additional medical support, alongside the specific protocols required to manage complications associated with injectable treatments.

At KEIT Day Hospital, patient care continues after LOLA treatment has been completed. Patients receive personalised instructions on skincare, hydration, sun protection and precautions to follow during the first few days.
Follow-up is determined according to the patient's individual response to treatment. Follow-up appointments, when indicated, allow the doctor to assess improvements in skin hydration, texture and elasticity, while checking for any persistent reactions and the need for additional sessions.
For international patients, care may also continue remotely through communication with medical staff and guidance on necessary follow-up appointments. KEIT Day Hospital also provides an emergency contact number, available 24 hours a day, 7 days a week.

KEIT Day Hospital places particular emphasis on transparent information and treatment documentation. Before LOLA treatment, patients receive explanations about the product used, the areas to be treated, the approximate number of sessions, expected benefits, the variable duration of results and potential risks.
Clinical documentation records the product's brand name, batch number, quantity administered and injection sites, ensuring traceability of the procedure. When appropriate and with the patient's consent, photographic documentation is taken to compare the initial skin condition with the results obtained. The informed consent form, treatment quotation and administrative documentation also allow patients to understand the clinical and financial aspects of the treatment process before undergoing treatment.